Modulators of 14-3-3 Protein–Protein Interactions-Reference-Cited by-同舟云学术

Modulators of 14-3-3 Protein–Protein Interactions

Published:2017-10-02 Issue:9 Volume:61 Page:3755-3778
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Stevers Loes M.¹,Sijbesma Eline¹,Botta Maurizio²^ORCID,MacKintosh Carol³,Obsil Tomas⁴,Landrieu Isabelle⁵,Cau Ylenia²,Wilson Andrew J.⁶⁷,Karawajczyk Anna⁸,Eickhoff Jan⁹,Davis Jeremy¹⁰,Hann Michael¹¹,O’Mahony Gavin¹²^ORCID,Doveston Richard G.¹,Brunsveld Luc¹^ORCID,Ottmann Christian¹¹³^ORCID

Affiliation:

1. Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, P.O. Box 513, 5600 MB, Eindhoven, The Netherlands

2. Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy

3. Division of Cell and Developmental Biology, School of Life Sciences, University of Dundee, Dundee DD1 4HN, United Kingdom

4. Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Prague 116 36, Czech Republic

5. Université deLille, CNRS, UMR 8576, F 59 000 Lille, France

6. School of Chemistry, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, United Kingdom

7. Astbury Center For Structural Molecular Biology, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, United Kingdom

8. Taros Chemicals GmbH & Co. KG, Dortmund 44227, Germany

9. Lead Discovery Center GmbH, Dortmund 44227, Germany

10. UCB Celltech, 216 Bath Road, Slough SL1 3WE, United Kingdom

11. GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom

12. Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca Gothenburg, Pepparedsleden 1, SE-431 83 Mölndal, Sweden

13. Department of Chemistry, University of Duisburg-Essen, Universitätstraße 7, 45141 Essen, Germany

Funder

Deutsche Forschungsgemeinschaft

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b00574

Reference164 articles.

1. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth